CN101810751B - 一种治疗小儿肠系膜淋巴结发炎的中药制剂 - Google Patents
一种治疗小儿肠系膜淋巴结发炎的中药制剂 Download PDFInfo
- Publication number
- CN101810751B CN101810751B CN2010101621491A CN201010162149A CN101810751B CN 101810751 B CN101810751 B CN 101810751B CN 2010101621491 A CN2010101621491 A CN 2010101621491A CN 201010162149 A CN201010162149 A CN 201010162149A CN 101810751 B CN101810751 B CN 101810751B
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- chinese medicine
- medicine preparation
- inflammation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 102
- 238000002360 preparation method Methods 0.000 title claims abstract description 38
- 201000003265 lymphadenitis Diseases 0.000 title abstract 2
- 244000268590 Euryale ferox Species 0.000 claims abstract description 15
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 15
- 210000003038 endothelium Anatomy 0.000 claims abstract description 9
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 3
- 210000000582 semen Anatomy 0.000 claims description 54
- 206010061218 Inflammation Diseases 0.000 claims description 34
- 230000004054 inflammatory process Effects 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 238000010438 heat treatment Methods 0.000 claims description 19
- 241000628997 Flos Species 0.000 claims description 13
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 239000010271 massa medicata fermentata Substances 0.000 claims description 13
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000006187 pill Substances 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000005903 Dioscorea Nutrition 0.000 claims description 4
- 235000000504 Dioscorea villosa Nutrition 0.000 claims description 4
- 235000004879 dioscorea Nutrition 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 235000011837 pasties Nutrition 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 241000555682 Forsythia x intermedia Species 0.000 claims description 2
- 241000245240 Lonicera Species 0.000 claims description 2
- 241000219780 Pueraria Species 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims description 2
- 239000008298 dragée Substances 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- -1 electuary Substances 0.000 claims description 2
- 239000002662 enteric coated tablet Substances 0.000 claims description 2
- 239000007941 film coated tablet Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000007940 sugar coated tablet Substances 0.000 claims description 2
- 239000000829 suppository Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000234273 Dioscorea Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 27
- 235000013305 food Nutrition 0.000 abstract description 19
- 206010037660 Pyrexia Diseases 0.000 abstract description 17
- 206010061428 decreased appetite Diseases 0.000 abstract description 9
- 235000013399 edible fruits Nutrition 0.000 abstract description 7
- 230000014759 maintenance of location Effects 0.000 abstract description 7
- 235000019640 taste Nutrition 0.000 abstract description 6
- 208000022531 anorexia Diseases 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000013719 Houttuynia cordata Nutrition 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 230000008451 emotion Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 description 44
- 210000000952 spleen Anatomy 0.000 description 39
- 208000002193 Pain Diseases 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 34
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 28
- 201000010099 disease Diseases 0.000 description 26
- 210000002784 stomach Anatomy 0.000 description 25
- 206010011224 Cough Diseases 0.000 description 23
- 229940079593 drug Drugs 0.000 description 22
- 230000006870 function Effects 0.000 description 22
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 210000003734 kidney Anatomy 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 20
- 208000024891 symptom Diseases 0.000 description 15
- 206010000087 Abdominal pain upper Diseases 0.000 description 13
- 208000001848 dysentery Diseases 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 230000001142 anti-diarrhea Effects 0.000 description 12
- 235000009508 confectionery Nutrition 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 230000008961 swelling Effects 0.000 description 11
- 206010047700 Vomiting Diseases 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 208000004232 Enteritis Diseases 0.000 description 9
- 230000036528 appetite Effects 0.000 description 9
- 235000019789 appetite Nutrition 0.000 description 9
- 230000029087 digestion Effects 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 238000005057 refrigeration Methods 0.000 description 9
- 230000008673 vomiting Effects 0.000 description 9
- 208000000059 Dyspnea Diseases 0.000 description 8
- 206010013975 Dyspnoeas Diseases 0.000 description 8
- 210000001124 body fluid Anatomy 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 8
- 208000019902 chronic diarrheal disease Diseases 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 230000000968 intestinal effect Effects 0.000 description 8
- 201000007227 lymph node tuberculosis Diseases 0.000 description 8
- 230000003014 reinforcing effect Effects 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 230000001684 chronic effect Effects 0.000 description 6
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 230000001047 pyretic effect Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 230000035807 sensation Effects 0.000 description 6
- 235000019615 sensations Nutrition 0.000 description 6
- 210000001113 umbilicus Anatomy 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000018044 dehydration Effects 0.000 description 5
- 238000006297 dehydration reaction Methods 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 241001508464 Orobanche Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 208000013116 chronic cough Diseases 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 229960001259 diclofenac Drugs 0.000 description 4
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 4
- 229960002986 dinoprostone Drugs 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000003026 hypopharynx Anatomy 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 4
- 210000004915 pus Anatomy 0.000 description 4
- 239000009254 shuang-huang-lian Substances 0.000 description 4
- 230000002269 spontaneous effect Effects 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010033971 Paratyphoid fever Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 208000004396 mastitis Diseases 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 238000004064 recycling Methods 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 230000035943 smell Effects 0.000 description 3
- 238000012109 statistical procedure Methods 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- ATWHGWYKSFRYBN-UHFFFAOYSA-N Amygdaloside Natural products O1C(=O)C2(C)CCCC(C3CC4)(C)C2C1OCC3(C1)CC4C1(O)COC1OC(CO)C(O)C(O)C1O ATWHGWYKSFRYBN-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoylacetaldehyde Natural products CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010015958 Eye pain Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000005168 Intussusception Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010024642 Listless Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000037062 Polyps Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 241000702670 Rotavirus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 239000000571 coke Substances 0.000 description 2
- 206010009887 colitis Diseases 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 239000010135 fructus aurantii immaturus Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000007952 growth promoter Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 208000011140 intestinal infectious disease Diseases 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 150000002630 limonoids Chemical class 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000002601 radiography Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000008359 toxicosis Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- XLYLQUQHYUOPIW-UHFFFAOYSA-N 3-oxo-Tetradecanal Chemical compound CCCCCCCCCCCC(=O)CC=O XLYLQUQHYUOPIW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000013824 Acidemia Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 1
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 244000281702 Dioscorea villosa Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 241000607757 Xenorhabdus Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940125714 antidiarrheal agent Drugs 0.000 description 1
- 239000003793 antidiarrheal agent Substances 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 108010089934 carbohydrase Proteins 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 235000021551 crystal sugar Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000001842 enterocyte Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000009090 lianfang Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000012771 pancakes Nutrition 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- CASUWPDYGGAUQV-UHFFFAOYSA-M potassium;methanol;hydroxide Chemical compound [OH-].[K+].OC CASUWPDYGGAUQV-UHFFFAOYSA-M 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical class [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 208000010540 rapid respiration Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 210000001034 respiratory center Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940063674 voltaren Drugs 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种治疗小儿肠系膜淋巴结发炎的中药制剂,各种组份的重量份数比为:山楂10~15份,莲肉10~15份,炒芡实10~15份,五味子10~15份,鱼腥草10~15份,地骨皮10~15份,杏仁10~15份,白术10~15份,山药10~15份,茯苓10~15份,甘草10~15份,陈皮10~15份,枳壳10~15份,大枣10~15份。当病儿有发热时加入连翘5~10份,夏枯草5~10份,金银花10~15份,葛根10~15份。当病儿有积食,厌食现象时加焦三仙各10份,鸡内金10~15份。本发明安全,毒副作用小,精选气味平和的中药,使其中药气味并不浓烈,适合儿童口感,让儿童不至于产生厌烦情绪,达到理想的治疗效果。
Description
技术领域
本发明涉及含有来源于植物、动物或矿物组份的医用配制品,特别涉及一种治疗小儿肠系膜淋巴结发炎的中药制剂。
背景技术
临床上,常见到许多小儿在上呼吸道感染的同时并发肠系膜淋巴结发炎,主要表现为:脐周疼痛,恶心,呼纳差,面色萎黄,精神不振,手足心热,并且可以转为慢性,对小儿的健康成长有着非常不利的影响。在中医的角度上,从属于小儿腹痛病证。小儿腹痛首见于《小儿药证直诀》。临床分寒实腹痛、积热腹痛、伤湿腹痛、积痛、虫痛、锁肚痛、盘肠钓痛、癥瘕痛、虚寒腹痛等。肠系膜淋巴结发炎可散见于上述病证。临床上对小儿肠系膜淋巴结发炎的内科治疗多是抗菌消炎、对症处理,并无良策,让众多小儿饱受痛苦。
一般医生针对这样的情况都主张利用抗生素治疗:细菌性肠炎可用抗生素治疗。因细菌之抗药性逐渐改变,用药时需由医师指导,依医师处方服用。但病儿原本体弱,症状刚刚变好就停药,结果因用药不够,而发生慢性大肠炎,日久不愈,影响小儿之营养及健康。再就是静脉点滴,下痢最危险为脱水,小儿比成人更容易脱水,厉害者可以脱水体重1/10以上,脱水死亡率可达30%。补充水分则可将死亡率减低到5%以下,所以下痢的最好治疗方法为点滴。在病重时肠管肿胀,不吸收水份,喝一次水泻一次,在这种情形病童一定要点滴治疗,补充食盐水及葡萄糖;酸血症厉害时补充碱液,缺乏钾时补充钾分。
点滴除补充营养水分电解质水外,尚有止泻作用。当一切止泻药剂无效时,点滴更是最好的止泻疗法。但病儿身体虚弱,对营养需求较大,点滴解决不了。当发生肠套叠时孩子一定伴有明显的腹痛,哭闹不止、当发生息肉时,会出现持续少量出血,只有特殊肠道造影才能确诊,以及正常肠粘膜代谢性脱落,孩子没有任何异样表现,生长发育正常等。临床上对小儿肠系膜淋巴结发炎的内科治疗多是抗菌消炎、对症处理,并无良策,让众多小儿饱受痛苦,并没有治标治本的良药来彻底解决这个问题。
发明内容
本发明所要解决的技术问题在于,提供了一种治疗小儿肠系膜淋巴结发炎的中药制剂,本发明中药制剂配方简单、制作工艺简便,能很快的控制腹痛,腹泻,发热的症状,长期服用能够根除病证。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发。
为解决上述技术问题,本发明提供了一种的治疗小儿肠系膜淋巴结发炎的中药制剂,所述制剂中各种组份的重量份数比为:山楂10~15份,莲肉10~15份,炒芡实10~15份,五味子10~15份,鱼腥草10~15份,地骨皮10~15份,杏仁10~15份,白术10~15份,山药10~15份,茯苓10~15份,甘草10~15份,陈皮10~15份,枳壳10~15份,大枣10~15份。
所述治疗小儿肠系膜淋巴结发炎的中药制剂,当病儿有发热时可以加入连翘5~10份,夏枯草5~10份,金银花10~15份,葛根10~15份。
所述治疗小儿肠系膜淋巴结发炎的中药制剂,当病儿有积食,厌食现象时可以加入焦三仙各10份,鸡内金10~15份。
所述治疗小儿肠系膜淋巴结发炎的中药制剂,所述药物剂型可以为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、丸剂、散剂、膏剂、丹剂、混悬剂、溶液剂、注射剂、栓剂、软膏剂、硬膏剂、霜剂、喷雾剂、滴剂或贴剂等。
为解决上述技术问题,本发明还提供了一种治疗小儿肠系膜淋巴结发炎的中药制剂的制备方法,所述中药制剂剂型为胶囊剂时的制备方法包括:
a.将鱼腥草放入乙醇中加热回流提取;
b.再取上述方中的剩余组份,加水加热回流提取;
c.将上述两种提取液合并,减压回收乙醇并浓缩抽滤吸附,得到组份药;装入胶囊制为胶囊剂。
所述步骤a中,可以将鱼腥草放入10倍量乙醇中,加热回流提取2次,每次30分钟~45分钟,提取活性成份,将2次提取液合并静置。
所述步骤b中,可以将剩余组份放入10倍量水中,加热回流提取3次,每次30分钟~45分钟,将3次提取液合并静置。
所述步骤c中,可以将上述两种提取液合并,减压回收乙醇并浓缩至药液浓度为0.6g生药/mL,抽滤后,滤液的相对密度约为20℃时1.06;上述滤液经体积为10L的大孔吸附树脂柱吸附;吸附之后用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的乙醇洗脱,收集乙醇洗脱液,去除乙醇溶剂,得到组份药粉,装入胶囊制为胶囊剂。
为解决上述技术问题,本发明还提供了一种治疗小儿肠系膜淋巴结发炎的中药制剂的制备方法,所述中药制剂剂型为蜜炼丸剂,其制备方法包括:
将所述中药制剂的组份加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;滤渣再加水,第三次加热煮沸30~40分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱70℃~80℃烘干后冷却,烘干后冷却,与蜂蜜混在一起搓成细条;以5g为一丸腊封包装。
与现有技术相比教,本发明治疗小儿肠系膜淋巴结发炎的中药制剂具有给药方便,药剂易于制造,成本低廉等优点。虽然本发明为中药制剂,但精选气味平和的中药,使中药制剂的气味并不浓烈,适合儿童口感,让儿重不至于产生厌烦情绪。本发明采用不同药性的中药材,进行了科学配伍,能达到理想的治疗效果,且安全,毒副作用小,使用方便,治愈时间短,治愈后不易复发。能创造较好的社会价值及经济利益。
具体实施方式
临床上,常见到许多小儿在上呼吸道感染的同时并发肠系膜淋巴结发炎,主要表现为:脐周疼痛,恶心,呼纳差,面色萎黄,精神不振,手足心热,并且可以转为慢性,对小儿的健康成长有着非常不利的影响。在中医的角度上,从属于小儿腹痛病证。小儿腹痛首见于《小儿药证直诀》。临床分寒实腹痛、积热腹痛、伤湿腹痛、积痛、虫痛、锁肚痛、盘肠钓痛、癥瘕痛、虚寒腹痛等。肠系膜淋巴结发炎可散见于上述病证。临床上对小儿肠系膜淋巴结发炎的内科治疗多是抗菌消炎、对症处理,并无良策,让众多小儿饱受痛苦。一般医生针对这样的情况都主张利用抗生素治疗:细菌性肠炎可用抗生素治疗。因细菌之抗药性逐渐改变,用药时需由医师指导,依医师处方服用。但病儿原本体弱,症状刚刚变好就停药,结果因用药不够,而发生慢性大肠炎,日久不愈,影响小儿之营养及健康。当发生肠套叠时孩子一定伴有明显的腹痛,哭闹不止、当发生息肉时,会出现持续少量出血,只有特殊肠道造影才能确诊,以及正常肠粘膜代谢性脱落,孩子没有任何异样表现,生长发育正常等。
小儿肠系膜淋巴结发炎主要表现为腹痛、腹泻、腹胀,少数孩子还会出现呕吐和肠道出血。发生时经常是“来势汹汹”,令人不知如何应对。宝宝小的时候身体是很容易受到外界环境影响的,有些宝宝肠胃很不好,有些是消化问题,有些是肠道出现了病变,最常见的有肠炎、胃炎等。引起此病的原因很多,较常见的有下列数种:
病童除了有水状腹泻外,发烧、呕吐、伤风的症状也常出现,这种病毒还会攻击肠细胞的乳糖接受器而使得乳糖消化不良,因此吃了一般奶粉会持续性地下泻。有些病例常被误以为是肠炎未好,而连续吃了几个月的拉肚子药,却不见改善,此时应考虑更换为不含乳糖的止泻奶粉。另外,有些慢性腹泻是由于食物过敏.如:牛奶、蛋、大豆或海鲜等,吃了这些食物后,就发生呕吐、下泻的症状,这种病例则须做过敏检查,找出原因。大多数小儿肠系膜淋巴结发炎是感染细菌或病毒等病菌后引起的,导致此病的病菌种类繁多,其中以病毒最为多见,如轮状病毒、腺病毒、柯萨奇病毒等,不过症状一般比较轻微。由细菌引发的肠炎则症状较重,其中常见细菌有空肠弯曲菌、沙门氏菌、痢疾杆菌、致病性大肠杆菌、金黄色葡萄球菌等。医生诊断此病的主要是根据腹痛、腹胀、腹泻等临床症状以及肠炎发生的季节、腹泻的大便性状来判断引起肠炎的原因。在秋冬季出现的2岁以下孩子流行性腹泻,粪便呈蛋花样或白色水样,那么患轮状病毒肠炎的可能性大;如肠炎发生在夏季,则由致病性大肠杆菌引起的可能性大;如果大便中含有黏液、脓血,则有可能是细菌性痢疾、空肠弯曲菌肠炎等。看到孩子腹泻,家长都迫切想止泻。其实,医生一般不主张马上使用止泻药,因为这样做有可能延迟病菌从孩子体内排出,不仅起不到治疗作用,反而会加重病情。当小儿肠系膜淋巴结发炎伴发严重全身症状,如高热持续不退,呕吐频繁,腹泻严重并持续,大便带脓血,出现口唇干燥、小便减少等脱水症状,要及时去医院治疗。小儿腹泻时,会丢失大量水分,容易出现脱水,所以,预防和治疗脱水是治疗中一项重要措施。要鼓励孩子多喝水,以补足水分。口服补液盐适合在家庭中应用,可以有效预防和治疗患儿脱水,可以少量多次让孩子喝,特别是在每次腹泻或呕吐后,要让孩子喝10~15毫升。在腹泻时和腹泻后的短时间内,可以在医生指导下适量补充微量元素锌,可以减轻和缩短腹泻病程,预防再次发生感染性腹泻。在此病发病初期,孩子食欲会明显减退,特别是伴有呕吐的孩子。此时不必强迫孩子进食,但要保证水分供应,鼓励孩子少量多次饮用口服补液盐或者白开水。婴幼儿胃肠道功能比较差,对外界感染的抵抗力低,稍有不适就容易得小儿肠系膜淋巴结发炎。
本发明的技术方案中,五味子益气敛阴,助补气生阴之力;白术滋阴润燥、清热除烦;茯苓,杏仁养心安神;大枣,莲肉,炒芡实和山药补脾益肾,载药上行,使药力上行,可行气血,使诸药滋而不腻,补不留瘀;枳壳化瘀除湿;鱼腥草消炎化瘀;陈皮开胃消食,甘草调和诸药;地骨皮补脾益气;诸药合用补行兼施,共奏益气滋阴养血,行气活血止痛之功。连翘,金银花清热消肿,解毒化瘀,夏枯草利肝健脾,葛根清热消烦,这四味药是清热的良药;焦三仙和鸡内金健脾消食,是治疗小儿厌食,积食的良药。
山楂:中医认为,山楂具有消积化滞、收敛止痢、活血化淤等功效。主治饮食积滞、胸膈痞满、疝气血淤闭经等症。山楂中含有山萜类及黄铜类等药物成分,具有显著的扩张血管及降压作用,有增强心肌、抗心律不齐、调节血脂及胆固醇含量的功能。《本草经疏》:山楂,《本经》云味酸气冷,然观其能消食积,行瘀血,则气非冷矣。有积滞则成下痢,产后恶露不尽,蓄于太阴部分则为儿枕痛。山楂能入脾胃消积滞,散宿血,故治水痢及产妇腹中块痛也。大抵其功长于化饮食,健脾胃,行结气,消瘀血。
莲肉是秋季果实成熟时采割莲房,除去莲心者称莲肉,取出果实,除去果皮,干燥。甘、涩,平。归脾、肾、心经。功能与主治补脾止泻,益肾涩精,养心安神。用于脾虚久泻,遗精带下,心悸失眠。莲肉比较平和,《纲目》载其:交心肾,厚肠胃,固精气,强筋骨,补虚损,利耳目,除寒湿,止脾泄久痢,赤白浊,女人带下崩中诸血病。
炒芡实固肾涩精,补脾止泄。治遗精,淋浊,带下,小便不禁,大便泄泻。(1)健脾止泻:用于脾虚泄泻,常配山药、白术补中益气,为滋养强壮性食物,和莲子有些相似,但芡实的收敛固精作用比莲子强,适用于慢性泄泻和小便频数,梦遗滑精,妇女带多腰酸等。慢性泄泻,包括慢性肠结核,五更泄泻等。《本草从新》:补脾固肾,助气涩精。
五味子温;酸、甘;归肺、心、肾经。收敛固涩,益气生津,补肾宁心。用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。果实作中药功能益气生津、敛肺滋肾、止泻、涩精、安神,可治久咳虚喘、津少口干、遗精久泻、健忘失眠等症。五味子果实作中药功能益气生津、敛肺滋肾、止泻、涩精、安神,可治久咳虚喘、津少口干、遗精久泻、健忘失眠等症。药理试验证明能调节中枢神经系统的兴奋和抑制过程,促进肌体代谢,调节胃液和胆液分泌,对肝炎恢复期转氨酶升高者有降低作用。《本草汇言》五味子,敛气生津之药也。故《唐本草》主收敛肺虚久嗽耗散之气。凡气虚喘急,咳逆劳损,精神不足,脉势空虚,或劳伤阳气,肢体赢瘦,或虚气上乘,自汗频来,或精元耗竭,阴虚火炎,或亡阴亡阳,神散脉脱,以五味子治之,咸用其酸敛生津,保固元气而无遗泄也。然在上入肺,在下入肾,入肺有生津济源之益,入肾有固精养髓之功。
杏仁归肺;脾;大肠经苦杏仁中含有苦杏仁苷,苦杏仁苷在体内能被肠道微生物酶或苦杏仁本身所含的苦杏仁酶水解,产生微量的氢氰酸与苯甲醛,对呼吸中枢有抑制作用,达到镇咳、平喘作用。杏仁味苦下气,且富含脂肪油。脂肪油能提高肠内容物对黏膜的润滑作用,故杏仁有润肠通使之功能。《本草纲目》:杏仁能散能降,故解肌、散风、降气、润燥、消积,治伤损药中用之。治疮杀虫,用其毒也。治风寒肺病药中,亦有连皮尖用者,取其发散也。
白术味苦、甘,温。归脾、胃经。主治健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。《药性论》载其:君,味甘,辛,无毒。能主大风痹,多年气痢,心腹胀痛,破消宿食,开胃,去痰涎,除寒热,止下泄。主面光悦,驻颜,去黑。治水肿胀满,吐呕逆,腹内冷痛,吐泻不住,及胃气虚冷痢。
山药味甘、性平,入肺、脾、肾经;不燥不腻,有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效;主治脾胃虚弱、倦怠无力、食欲不振、久泄久痢、肺气虚燥、痰喘咳嗽、肾气亏耗、腰膝酸软、下肢痿弱、消渴尿频、遗精早泄、带下白浊、皮肤赤肿、肥胖等病症。《本草纲目》概括五大功用“益肾气,健脾胃,止泄痢,化痰涎,润皮”。山药煮粥或者用冰糖煨熟后服用,对身体差、肠炎、肾亏等慢性病均有疗效。补益脾胃:治疗脾胃虚弱、泄泻、体倦、食少、虚汗。益肺滋肾:本品不寒不燥,味甘质润,可治疗肺肾虚损的消渴、遗精、带下等病证。被誉为神仙药。
甘草性平,味甘,归十二经。有解毒、祛痰、止痛、解痉以至抗癌等药理作用。在中医上,甘草补脾气,滋咳润肺,缓急解毒,调和百药。临床应用分“生用”与“蜜炙”之别。生用主治咽喉肿痛,痛疽疮疡,胃肠道溃疡以及解药毒、食物中毒等;蜜炙主治脾胃功能减退,大便溏薄,乏力发热以及咳嗽、心悸等。用于痈疽疮疡、咽喉肿痛等。可单用,内服或外敷,或配伍应用。痈疽疮疡,常与金银花、连翘等同用,共奏清热解毒之功,如仙方活命饮。咽喉肿痛,常与桔梗同用,如桔梗汤。若农药、食物中毒,常配绿豆或与防风水煎服。用于气喘咳嗽。可单用,亦可配伍其他药物应用。如治湿痰咳嗽的二陈汤;治寒痰咳喘的苓甘五味姜辛汤;治燥痰咳嗽的桑杏汤;治热毒而致肺痈咳唾腥臭脓痰的桔梗汤;治咳唾涎沫的甘草干姜汤等。另风热咳嗽、风寒咳嗽、热痰咳嗽亦常配伍应用。
陈皮温;辛、苦;归脾、肺经陈皮的苦味物质是以柠檬苷和苦味素为代表的“类柠檬苦素”,这种类柠檬苦素味平和,易溶解于水,有助于食物的消化。陈皮用于烹制菜肴时。其苦味与其他味道相互调和,可形成独具一格的风味。陈皮含有挥发油、橙皮甙、维生素B、C等成分,它所含的挥发油对胃肠道有温和刺激作用,可促进消化液的分泌,排除肠管内积气,增加食欲。陈皮也是一味常用中药,具有通气的健脾、燥湿化痰、解腻留香、降逆止呕的功效。
枳壳苦、辛、酸,温。归脾、胃经。功能理气宽中,行滞消胀。用于胸胁气滞,胀满疼痛,食积不化,痰饮内停;胃下垂,脱肛,子官脱垂。.《本草经疏》:枳壳,气味所主,与枳实大略相同。但枳实形小,其气全,其性烈,故善下达;枳壳形大,其气散,其性缓,故其行稍迟,是以能人胸膈肺胃之分及入大肠也。其主风痒麻痹,通利关节,止风痛者,盖肺主皮毛,胃主肌肉,风寒湿入于二经,则皮肤瘙痒,或作痛,或麻木,此药有苦泄辛散之功,兼能引诸风药入于二脏,故为治风所需,风邪既散,则节自然通利矣。其疗劳气咳嗽,背膊闷倦者,盖亦指风寒郁于上焦,则肺气滞而为闷倦咳嗽。
夏枯草微苦,清肝、散结、利尿;治瘟病、乳痈、目痛、黄疸、淋病、高血压等症;治淋巴结核、甲状腺肿大、瘰疬、瘿瘤、乳痈、乳癌、目珠夜痛、羞明流泪、头目眩晕、口眼歪斜、筋骨疼痛、肺结核、急性黄疸型传染性肝炎、血崩、带下。夏枯草为清肝火、散郁结的要药,它所主治的大多是肝经的病症。本品配以菊花、决明子,可清肝明目,治目赤肿痛、配以石决明、钩藤,可平降肝阳,治头痛、头晕;配以玄参、贝母、牡蛎等品,可软坚散结,治瘰历结核。《滇南本草》:祛肝风,行经络,治口眼歪斜。行肝气,开肝郁,止筋骨疼痛、目珠痛,散瘰窃、周身结核。《生草药性备要》:去痰消脓,治瘰疬,清上补下,去眼膜,止痛。它药效较为平和,味道也不是很苦,适宜小孩口感!
连翘苦,微寒。归肺、心、小肠经。功能是清热解毒,消肿散结。用于痈疽,瘰疬,乳痈,丹毒,风热感冒,温病初起,温热入营,高热烦渴,神昏发斑,热淋尿闭。连翘药用部分主要是果实。它的果壳,即“芩翘解毒丸”中的“翘”。含有连翘酚、香豆精、齐墩果酸、皂甙、维生素P等。具有清热、解毒、散结排脓等功效。主治温热、疮疡、瘰疬、丹毒、班疹、流感,用果实水煎服,或加入方剂中。常用于风热感冒。性味功能:中药味苦,性微寒。清热解毒,散结消肿。蒙药味苦,性凉。清“协日”,止泻。主治:中药治热病初起,风热感冒,发热,心烦,咽喉肿痛,斑疹,丹毒,瘰疬,痈疮肿毒,急性肾炎,热淋。蒙药治黄疸,肠刺痛,“协日”病,肠热。神农本草经》:主寒热,鼠痿,瘰疬,痈肿,恶疮,瘿瘤,结热,蛊毒。
葛根解表退热,生津,透疹,升阳止泻。用于外感发热头痛、高血压颈项强痛、口渴、消渴、麻疹不透、热痢、泄泻。《本草纲目》载:葛根,性凉、气平、味甘,具清热、降火、排毒诸功效。现代医学研究表明:葛根中的异黄酮类化合物葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。升举阳气,止渴止泻葛根轻清升散,药性升发,柳举阳气,鼓舞机体正气上升,津液布行。升发脾胃清阳空气而止渴,止泻痢。故常用于治疗内热消渴,麻疹透发不畅,腹泻、痢疾等病症。
焦三仙是三味药,即焦麦芽、焦山楂、焦神曲。这三味药均有良好的消积化滞功能,但又有各自不同的特点。焦麦芽有很好的消化淀粉类食物的作用;焦山楂善于治疗肉类或油腻过多所致的食滞;焦神曲则利于消化米面食物。三药合用,能明显地增强消化功能。因此,临床上医生常将三药合用并称为“焦三仙”。
麦芽,经大麦发芽而成,将麦芽置锅内微炒至黄色,喷洒清水,取出晒干,即为焦麦芽。焦麦芽具有健脾和胃、舒肝化滞之功,用于治疗食积不消、脘腹胀满、食欲不振、呕吐泄泻等症。现代研究认为,麦芽中富含淀粉分解酶、转化糖酶、脂化酶、维生素B等,有良好的助消化作用。
山楂,切片晒干,置锅内用武大炒至外面焦褐色、内部黄褐色为度、喷洒清水,取出晒干,即为焦山楂。口服山楂能增加消化酶,促进脂肪的分解和消化,对因吃肉类或油腻过多所致脘腹胀满、嗳气、不思饮食、腹痛、腹泻者,疗效尤佳。此外,现代药物试验表明,山楂有缓慢而持久的降低血压的功效,还可降低胆固醇和甘油三酯,防止动脉粥样硬化,而且还可舒张冠状动脉,增加心肌收缩力,对抗心律失常。因此,有利于防治高血压、高血脂、动脉硬化及冠心病。
神曲,为全麦粉和其他药物(青蒿、苍耳,辣蓼、杏仁、赤小豆等芽)混合后经发酵而成的加工品。取神曲置锅内炒至外表呈焦黑色、内部焦黄色,取出,喷洒些消水,放凉,即为焦神曲。神曲经发酵而成,凡发酵之品都有健脾胃助消化的作用,因此,对于饮食内伤所致的消化的不良、胸痞腹胀颇有效验。
鸡内金甘,寒。归脾、胃、小肠、膀胱经。消食健胃,涩精止遗。鸡内金含胃激素、角蛋白、氨基酸以及微量胃蛋白酶、淀粉酶等。口服鸡内金粉后,胃液的分泌量、酸度和消化力均增高,胃运动加强、排空加快。其酸提取液或煎剂能加速从尿中排除放射性锶。
地骨皮性味性寒,味甘。功能主治凉血除蒸,清肺降火。用于阴虚潮热、骨蒸盗汗、肺热咳嗽、咯血、衄血。地骨皮对人工发热家兔有显著退热作用。其乙醚提取物及乙醇提取后残渣之水提取物并无作用,而乙醇提取物、水提取物或乙醚提取后残渣的水提取物皆有作用。其解热作用比氨基比林弱,约与其他解热药相等。《本草述》:″主治虚劳发热,往来寒热,诸见血证、鼻衄、咳嗽血,咳嗽、喘,消瘅,中风,眩晕,痉痼,腰痛,行痹,脚气,水肿,虚烦,悸,健忘,小便不通,赤白浊。″
鱼腥草辛,微寒。归肺经,入药,中医认为其味辛、性寒凉,能清热解毒、排痛消肿疗疮、利尿除湿、健胃消食,用治实热、热毒、湿邪、疾热为患的肺痈、疮疡肿毒、痔疮便血、脾胃积热等,单用或配伍复方,内服外用或民间多种食疗方法的使用均疗效确切。药理研究,鱼腥草主含挥发油,癸酰乙醛鱼腥草素等多种成份,对各种致病杆菌、球菌、流感病毒、钩端螺旋体等有抑制抗菌作用,并能提高人体免疫调节功能。
金银花清热散毒,《本草纲目》载“金银花,善于化毒,故治痈疽、肿毒、疮癣......”。自古以来,金银花常用于清热解毒,治疗温病发热,热毒血痢,痈疡等症。现代药理研究表明,金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用中医认为,金银花性寒、味甘、气平,具有清热解毒之功效,可以治疗热毒肿疡、痈疽疔疮等症。且兼有宣散作用。金银花清热解毒作用颇强。
大枣富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及钙、磷、铁和环磷酸腺苷等营养成分中医中药理论认为,红枣具有补虚益气、养血安神、健脾和胃等作用,是脾胃虚弱、气血不足、倦怠无力、失眠多梦等患者良好的保健营养品果。大枣补中益气,养血安神。用于脾虚食少,乏力便溏,妇人脏躁。能行气,活血,
茯苓甘、淡,平。归心、肺、脾、肾经。功能利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。《本经》载其:″主胸胁逆气,忧恚惊邪恐悸,心下结痛,寒热烦满,咳逆,口焦舌干,利小便。″《别录》:″止消渴,好睡,大腹,淋沥,膈中痰水,水肿淋结。开胸腑,调脏气,伐肾邪,长阴,益气力,保神守中。″《药性论》:″开胃,止呕逆,善安心神。主肺痿痰壅。治小儿惊痫,心腹胀满,妇人热淋。″
本发明蜜炼丸剂的制作过程为:取山楂1000g,莲肉1000g,炒芡实1000g,五味子1000g,鱼腥草1000g,地骨皮1000g,杏仁1000g,白术1000g,山药1000g,茯苓1000g,甘草1000g,陈皮1000g,枳壳1000g,大枣1000g。把药材加水浸泡30分钟至1小时,加热煮沸30分钟,过滤,滤液备用;滤渣加水,第二次加热,煮沸30分钟,再过滤,滤液备用;滤渣再加水,第三次加热煮沸30分钟,过滤;将三次滤液合在一起,加热浓缩至糊状,放入烘箱,控制在75℃,烘干后冷却成粉末状与蜂蜜混和在一起搓成细条;以每5g为一丸腊封包装。
本发明当小儿发热时胶囊剂的制作过程为:取连翘500g,夏枯草500g,金银花1000g,葛根1000g,山楂1000g,莲肉1000g,炒芡实1000g,五味子1000g,鱼腥草1000g,地骨皮1000g,杏仁1000g,白术1000g,山药1000g,茯苓1000g,甘草1000g,陈皮1000g,枳壳1000g,大枣1000g。
先将鱼腥草放入10倍量乙醇中,加热回流提取2次,每次45分钟,提取活性成份,将2次提取液合并静置。再将剩余药材加10倍量水,加热回流提取3次,每次1小时,将3次提取液合并;合并上述两种提取液,减压回收乙醇并浓缩至药液浓度为0.5g生药/mL,抽滤后,滤液的相对密度约为1.06(20℃);上述滤液经体积为10L的大孔吸附树脂柱,先用10倍树脂柱体积的去离子水或蒸馏水洗脱,再用5倍树脂柱体积的95%乙醇洗脱,收集乙醇洗脱液,去除溶剂,得到组份药;装入胶囊制为胶囊剂,每粒胶囊装0.3g。可以每12粒为一版。
本发明当小儿积食,消化不良时作为粉剂中成药的制作过程为:取焦三仙各1000g,鸡内金1000g,山楂1000g,莲肉1000g,炒芡实1000g,五味子1000g,鱼腥草1000g,地骨皮1000g,杏仁1000g,白术1000g,山药1000g,茯苓1000g,甘草1000g,陈皮1000g,枳壳1000g,大枣1000g。所述组份按配比混合,投入粉碎机粉碎成细粉,细粉过筛后放入耐酸碱浸渍锅内,在常温下,与乙醇共同浸渍10~20天,将浸渍好的液体及药渣进行压榨过滤,分离后取滤液,加热浓缩至糊状,放入烘箱,控制在100℃,烘干后冷却,粉碎后以每袋4~6g包装。
以下通过实验数据说明本发明的有益效果。
观察本发明的中药胶囊剂治疗小儿发热性肠系膜淋巴结发炎的中药制剂
一、解热作用:
1.对伤寒一副伤寒甲、乙三联菌苗致热家兔的解热作用:取家兔50只,实验前一天下午和当天上午,分别用电子测温计,预测肛温(超过39℃或一日内体温波动>0.6℃者剔除)取其平均值做为基础体温,逐只称重,经耳缘静脉,注入伤寒一副伤寒甲、乙三联菌苗0.75ml/kg,1小时后测其升温程度,以≥0.8℃视为合格,分成药物高、中、低剂量组、APC组、双黄连口服液和空白组,给药剂量分别为8.27g/kg、4.13g/kg、2.07g/kg、0.0233g/kg和3.06ml/kg,按5ml/kg兔重的体积灌胃,空白组给等体积的水灌胃。然后分别于给药0.5h、1.0h、1.5h、2.0h、3.0h、复测肛温,与基础体温比较然后计算温差,并将结果进行组间统计学处理(见表1)表1银牛颗粒解热作用(X±s,n=10)
| 组别 | 剂量 | 模前 | 0.5h | 1h | 2h | 3h |
| 正常组 | --- | 37.21±0.38 | 0.74±0.52 | 1.78±0.36 | 2.74±0.28 | 2.96±0.42 |
| 高剂量组 | 15.95 | 36.99±0.40 | 0.66±0.64 | 0.98±0.46 | 2.02±0.57 | 2.34±0.47 |
| 中剂量组 | 7.87 | 36.87±0.31 | 0.76±0.41 | 1.21±0.42 | 2.40±0.33 | 2.45±0.25 |
| 低剂量组 | 3.95 | 35.97±0.48 | 0.68±0.51 | 1.37±0.47 | 2.50±0.41 | 2.52±0.40 |
| APC组 | 0.045 | 36.85±0.38 | 0.57±0.49 | 0.84±0.62 | 2.06±0.48 | 2.23±0.50 |
| 双黄连口服液组 | 5.91 | 36.76±0.22 | 0.77±0.63 | 1.28±0.57 | 2.19±0.57 | 2.25±0.38 |
表1.结果表明本品有明显的解热作用,高、中剂量药后30分钟即可起效,可明显拮抗90-120分钟的发热高峰,解热作用可持续2-3小时;高剂量解热作用可持4-5小时。低剂量药后60分钟起效,抵抗90-120分钟的发热高峰作用不明显,解热作用可持续2小时。高剂量在高剂量在药后60-90分钟的解热作用上与APC相当。在拮抗90-120分钟的发热高峰方面以高剂量效果最佳,药后6小时的发热时程内与对照组比较分别有不同程度的显著性差异;提示本品对伤寒——副伤寒甲、乙三联菌苗致家兔发热模型有较好的治疗作用。
2.对大鼠炎症组织内PGE2合成的抑制作用
取160~180g左右大鼠50只,雌雄不拘随机分为5组,本发明中药制剂颗粒剂高、中、低剂量,扶他林对照组和空白对照组,每组10只,给药剂量同上,连续给药三天,末次药后1小时,右后足皮下注射1%角叉菜胶0.1ml,致炎后4小时,处死大鼠,在踝关节上0.5cm处剪下肿胀足,剥皮,剪碎,生理盐水5ml浸泡1小时,浸泡液离心(1500rpm)10分钟,吸取上清液0.1ml,加0.5mol/L的KOH-MeOH溶液2.0ml,50℃恒温异构20分钟,用甲醇稀释至20.0ml,在波长278nm处,用UV-2100紫外分光光度计测定其吸光度(A)值,结果进行组间t检验,结果见表2。
表2.本发明中药制剂胶囊剂对炎症组织内PGE2含量的影响(X±s,n=10)
| 组别 | 剂量(g/kg) | PGE2含量(A值) |
| 空白对照组 | --- | 0.0662±0.0107 |
| 高剂量组 | 15.95 | 0.0382±0.0094*** |
| 中剂量组 | 7.97 | 0.048±0.0164** |
| 低剂量组 | 3.99 | 0.0544±0.0091* |
| 扶他林组 | 0.00675 | 0.0382±0.0104*** |
注:与空白对照组比*P<0.05,**P<0.01,***P<0.001
表2结果可见:高、中、低剂量分别能不同程度地抑制大鼠炎症组织内PGE2的合成,高、中、低剂量与空白对照组比较分别有极显著性、非常显著性和显著性差异;经过统计学处理提示:其高剂量作用强度与扶他林相当。
三、对0.6%HAC致小鼠疼痛反应的镇痛作用:
取18~20g雄性健康小鼠若干,随机分为6组,本发明中药制剂胶囊剂高、中、低剂量,扶他林片组,双黄连口服液剂组和空白对照组,分别给予本发明中药制剂颗粒剂23.03g/kg、11.52g/kg、5.76g/kg、10.24g/kg,扶他林片9.75mg/kg,均按0.25ml/10g体重的体积灌胃给药,空白对照组给等体积的水灌胃给药,连续3天,分别测定末次药后1小时腹腔注射0.6%HAC 0.1ml/10g鼠重,记录出现扭体反应的潜伏期和15分钟内的扭体次数,结果进行组间统计学处理,按公式计算疼痛抑制率(%),数据分别见表3。
疼痛抑制率=(空白对照组扭体次数一药物组扭体次数)÷空白对照组扭体次数×100%
表3.本发明中药制剂胶囊剂对0.6%HAC致小鼠疼痛反应的影响(X±s,n=10)
| 组别 | 剂量(g/kg) | 扭体潜伏期(min) | 扭体次数(次) |
| 空白对照 | --- | 3.56±0.69 | 23.4±7.0 |
| 高剂量组 | 23.03 | 5.30±1.40** | 11.4±5.4*** |
| 中剂量组 | 11.52 | 4.74±1.12*** | 13.7±6.8** |
| 低剂量组 | 5.76 | 4.37±2.18 | 16.1±6.5* |
| 扶他林组 | 0.00975 | 6.91±2.09*** | 10.3±3.6*** |
| 双黄连口服液剂组 | 10.24 | 5.24±1.72 | 14.9±4.9 |
注:与空白对照组比*P<0.05,**P<0.01,***P<0.001
实施例1:高女,2岁,平素易于外感,体弱多病,抵抗力差,咳嗽流涕,每发则必见腹痛难耐,半月前,偶感风寒,服解表剂后,表证已解,但有脐周疼痛,恶心,食欲不振,面色萎黄,手足心热,微有汗出。前来就诊,方用取连翘5g,夏枯草5g,葛根10g,山楂10g,莲肉10g,炒芡实10g,五味子10g,列当10g,地骨皮10g,杏仁10g,白术10g,山药10g,茯苓10g,甘草10g,陈皮10g,枳壳10g,大枣10g。服药5天后自觉症状缓解,再服10剂而愈。
实施例2:曹某,男,4岁,病儿经常感觉脐周疼痛,恶心,食欲不振,面色萎黄,手足心热,微有汗出,积食,消瘦,拉稀,腹痛难耐前来就诊,方用山楂10g,莲肉10g,炒芡实10g,五味子10g,列当10g,地骨皮10g,杏仁10g,白术10g,山药10g,茯苓10g,甘草10g,陈皮10g,枳壳10g,大枣10g,焦三仙各10g,鸡内金10g,做成丸剂每日两丸,3天,症状缓解,开始有规律吃饭,再服15剂后痊愈。
实施例3:王某,女,3岁,病儿系早产,平素易于外感,体弱多病,抵抗力差,经常腹痛,哭闹不止,偶感风寒,服解表剂后,表证已解,但有脐周疼痛,食欲不振,面色萎黄,拉稀前来就诊,方用取山楂10g,莲肉10g,炒芡实10g,五味子10g,列当10g,地骨皮10g,杏仁10g,白术10g,山药10g,茯苓10g,甘草10g,陈皮10g,枳壳10g,大枣10g。服药5天后自觉症状缓解,再服20剂而愈。
实施例4:陈某,男,2岁,病儿体弱,平素易于外感,抵抗力差,经常腹痛,哭闹不止,脐周疼痛,呼纳差,面色萎黄,精神不振,手足心热,食欲不振,拉稀前来就诊,方用取山楂10g,莲肉10g,炒芡实10g,五味子10g,列当10g,地骨皮10g,杏仁10g,白术10g,山药10g,茯苓10g,甘草10g,陈皮10g,枳壳10g,大枣10g,金银花15g,连翘15g,葛根10g,夏枯草10g。服药5天后自觉症状缓解,再服15剂而愈。
Claims (5)
1.一种治疗小儿肠系膜淋巴结发炎的中药制剂,其特征在于,各种组份的重量份数比为:山楂10~15份,莲肉10~15份,炒芡实10~15份,五味子10~15份,鱼腥草10~15份,地骨皮10~15份,杏仁10~15份,白术10~15份,山药10~15份,茯苓10~15份,甘草10~15份,陈皮10~15份,枳壳10~15份,大枣10~15份。
2.一种治疗小儿肠系膜淋巴结发炎的中药制剂,其特征在于,各种组份的重量份数比为:山楂10~15份,莲肉10~15份,炒芡实10~15份,五味子10~15份,鱼腥草10~15份,地骨皮10~15份,杏仁10~15份,白术10~15份,山药10~15份,茯苓10~15份,甘草10~15份,陈皮10~15份,枳壳10~15份,大枣10~15份,连翘5~10份,金银花10~15份,夏枯草5~10份,葛根10~15份。
3.一种治疗小儿肠系膜淋巴结发炎的中药制剂,其特征在于,各种组份的重量份数比为:山楂10~15份,莲肉10~15份,炒芡实10~15份,五味子10~15份,鱼腥草10~15份,地骨皮10~15份,杏仁10~15份,白术10~15份,山药10~15份,茯苓10~15份,甘草10~15份,陈皮10~15份,枳壳10~15份,大枣10~15份,焦三仙各10份,鸡内金10~15份。
4.根据权利要求1~3中任一项所述治疗小儿肠系膜淋巴结发炎的中药制剂,其特征在于,所述中药制剂的剂型为:片剂、糖衣片剂、薄膜衣片剂、肠溶衣片剂、胶囊剂、硬胶囊剂、软胶囊剂、口服液、口含剂、颗粒剂、冲剂、丸剂、散剂、膏剂、丹剂、混悬剂、溶液剂、注射剂、栓剂、软膏剂、硬膏剂、霜剂、喷雾剂、滴剂或贴剂。
5.根据权利要求1~3中任一项所述治疗治疗小儿肠系膜淋巴结发炎的中药制剂,其特征在于,所述中药制剂的剂型为蜜丸剂,其制备方法包括:
将所述中药制剂各个组份加水浸泡30分钟至1小时,加热煮沸30~40分钟,过滤,滤液备用;
滤渣加水第二次加热,煮沸30~40分钟,过滤,滤液备用;
滤渣再加水,第三次加热煮沸30~40分钟,过滤,滤液备用;
将前述三次备用滤液混合在一起,加热浓缩至糊状,放入烘箱70℃~80℃烘干后冷却;
烘干后冷却,与蜂蜜混在一起搓成细条;以5g为一丸腊封包装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101621491A CN101810751B (zh) | 2010-05-05 | 2010-05-05 | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101621491A CN101810751B (zh) | 2010-05-05 | 2010-05-05 | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101810751A CN101810751A (zh) | 2010-08-25 |
| CN101810751B true CN101810751B (zh) | 2012-04-11 |
Family
ID=42618211
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101621491A Expired - Fee Related CN101810751B (zh) | 2010-05-05 | 2010-05-05 | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101810751B (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105267781A (zh) * | 2015-11-04 | 2016-01-27 | 赵娟 | 一种治疗肠系膜淋巴结炎的中药组合物及其制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433627A (zh) * | 2008-11-20 | 2009-05-20 | 郭传法 | 一种治疗小儿肠系膜淋巴结发炎的中药配方 |
-
2010
- 2010-05-05 CN CN2010101621491A patent/CN101810751B/zh not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433627A (zh) * | 2008-11-20 | 2009-05-20 | 郭传法 | 一种治疗小儿肠系膜淋巴结发炎的中药配方 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101810751A (zh) | 2010-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102048933B (zh) | 一种治疗小儿腹泻的中药组合物及其制备方法 | |
| CN101972338B (zh) | 一种治疗小儿上呼吸道感染的中药制剂及其制备方法 | |
| CN102198262B (zh) | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 | |
| CN101797326B (zh) | 一种治疗肠鸣腹泻的中药制剂及其制备方法 | |
| CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
| CN102106991A (zh) | 治疗中晚期肝癌化疗栓塞后的药 | |
| CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN104958646A (zh) | 一种润肠通便的中药制剂及其制备方法 | |
| CN101085328A (zh) | 一种内服治疗慢性胃炎的中药组合物 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN106994141B (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
| CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN104524358B (zh) | 一种辅助治疗缺铁性贫血的药丸及制备方法 | |
| CN102626509B (zh) | 一种治疗小儿黄疸的中药组合物 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN101810751A (zh) | 一种治疗小儿肠系膜淋巴结发炎的中药制剂 | |
| CN104740415A (zh) | 一种治疗哺乳期女性骨质疏松症的中药制剂 | |
| CN102335314B (zh) | 一种治疗胃病的中药组合物 | |
| CN100431584C (zh) | 一种健胸丰乳的中药制剂 | |
| CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
| CN105012732A (zh) | 一种用于治疗睡眠障碍综合征的中药丸剂及制备方法 | |
| CN105853882A (zh) | 一种用于治疗胃病的药物及制备方法 | |
| CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120411 Termination date: 20130505 |